Deborah Jorn

Deborah Jorn is the current director at Diurnal. Deborah has held various other positions in the past, including executive vice president and company group chair at Valeant Pharmaceuticals, global vice president of urology at Pharmacia Corporation, and group vice president allergy and respiratory at Schering-Plough. Jorn has also been a member of the board at Orexigen Therapeutics and held the title of VP global marketing at Bausch + Lomb.

Deborah Jorn has a MBA in Marketing & International Business from NYU Stern School of Business and a BA in Biochemistry from Rutgers University.